Follow
Hashem O. Alsaab
Hashem O. Alsaab
Associate Professor of Pharmaceutics and Pharmaceutical Technology at Taif University, Saudi Arabia
Verified email at wayne.edu - Homepage
Title
Cited by
Cited by
Year
PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome
HO Alsaab, S Sau, R Alzhrani, K Tatiparti, K Bhise, SK Kashaw, AK Iyer
Frontiers in pharmacology 8, 561, 2017
16412017
Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery
AK Sharma, A Gothwal, P Kesharwani, H Alsaab, AK Iyer, U Gupta
Drug Discovery Today 22 (2), 314-326, 2017
2252017
Phage display derived monoclonal antibodies: from bench to bedside
MA Alfaleh, HO Alsaab, AB Mahmoud, AA Alkayyal, ML Jones, SM Mahler, ...
Frontiers in immunology 11, 567223, 2020
2182020
Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy
JM Wickens, HO Alsaab, P Kesharwani, K Bhise, MCIM Amin, RK Tekade, ...
Drug discovery today 22 (4), 665-680, 2017
1782017
Advances in antibody–drug conjugates: A new era of targeted cancer therapy
S Sau, HO Alsaab, SK Kashaw, K Tatiparti, AK Iyer
Drug Discovery Today 22 (10), 1547-1556, 2017
1642017
Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment
S Sau, HO Alsaab, K Bhise, R Alzhrani, G Nabil, AK Iyer
Journal of controlled release 274, 24-34, 2018
1502018
Progress in clinical trials of photodynamic therapy for solid tumors and the role of nanomedicine
HO Alsaab, MS Alghamdi, AS Alotaibi, R Alzhrani, F Alwuthaynani, ...
Cancers 12 (10), 2793, 2020
1022020
Folic acid conjugated polymeric micelles loaded with a curcumin difluorinated analog for targeting cervical and ovarian cancers
D Luong, P Kesharwani, HO Alsaab, S Sau, S Padhye, FH Sarkar, AK Iyer
Colloids and Surfaces B: Biointerfaces 157, 490-502, 2017
952017
PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome. Front Pharmacol. 2017; 8: 561
HO Alsaab, S Sau, R Alzhrani, K Tatiparti, K Bhise, SK Kashaw, AK Iyer
Frontiers Media SA DOI 10, 2017
702017
Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages
HO Alsaab, S Sau, RM Alzhrani, VT Cheriyan, LA Polin, U Vaishampayan, ...
Biomaterials 183, 280-294, 2018
672018
CD44 directed nanomicellar payload delivery platform for selective anticancer effect and tumor specific imaging of triple negative breast cancer
Z Wang, S Sau, HO Alsaab, AK Iyer
Nanomedicine: nanotechnology, biology and medicine 14 (4), 1441-1454, 2018
642018
Nanomedicine for cancer diagnosis and therapy: Advancement, success and structure–activity relationship
K Bhise, S Sau, H Alsaab, SK Kashaw, RK Tekade, AK Iyer
Therapeutic delivery 8 (11), 1003-1018, 2017
622017
PDL-1 antibody drug conjugate for selective chemo-guided immune modulation of cancer
S Sau, A Petrovici, HO Alsaab, K Bhise, AK Iyer
Cancers 11 (2), 232, 2019
512019
Development of asialoglycoprotein receptor directed nanoparticles for selective delivery of curcumin derivative to hepatocellular carcinoma
S Yousef, HO Alsaab, S Sau, AK Iyer
Heliyon 4 (12), 2018
462018
The psychological impact of COVID-19 on healthcare workers in Saudi Arabia: a year later into the pandemic
AH Almalki, MS Alzahrani, FS Alshehri, A Alharbi, SF Alkhudaydi, ...
Frontiers in Psychiatry 12, 797545, 2021
442021
Organogels in drug delivery: A special emphasis on pluronic lecithin organogels
H Alsaab, SP Bonam, D Bahl, P Chowdhury, K Alexander, SHS Boddu
Journal of Pharmacy & Pharmaceutical Sciences 19 (2), 252-273, 2016
442016
PLGA-based nanomedicine: history of advancement and development in clinical applications of multiple diseases
HO Alsaab, FD Alharbi, AS Alhibs, NB Alanazi, BY Alshehri, MA Saleh, ...
Pharmaceutics 14 (12), 2728, 2022
432022
Folate decorated nanomicelles loaded with a potent curcumin analogue for targeting retinoblastoma
H Alsaab, RM Alzhrani, P Kesharwani, S Sau, SHS Boddu, AK Iyer
Pharmaceutics 9 (2), 15, 2017
422017
The possible relationship between the abuse of tobacco, opioid, or alcohol with COVID-19
YS Althobaiti, MA Alzahrani, NA Alsharif, NS Alrobaie, HO Alsaab, ...
Healthcare 9 (1), 2, 2020
392020
Designing a novel visible-light-driven heterostructure Ni–ZnO/SgC 3 N 4 photocatalyst for coloured pollutant degradation
A Bahadur, S Iqbal, HO Alsaab, NS Awwad, HA Ibrahium
RSC advances 11 (58), 36518-36527, 2021
362021
The system can't perform the operation now. Try again later.
Articles 1–20